Unlike the GLP-1 hormone, which is rapidly metabolized by the body, semaglutide and similar medications have much longer half-lives, meaning the medication can build up inside the body if not enough time elapses between doses
Doctors are more likely to misdiagnose medical conditions because they assume the problem is weight-related
For IBS & Food Intolerances: Features an 18-enzyme blend meticulously designed to target difficult-to-digest fermentable carbs (FODMAPs), helping to proactively prevent the gas, bloating, and pain associated with eating trigger foods
Incretins and cardiovascular disease: to the heart of type 2 diabetes
Under this multi-year supply contract, CordenPharma provides development and manufacturing services for clinical and commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735, a Dual GLP-1/GIP Receptor Agonist, across the full supply chain from drug substance to drug product for both its subcutaneous and oral peptide formulations